Importer of Controlled Substances; Notice of Registration, 53961 [2011-22088]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Notices
I conclude that Respondent’s
registration with the DEA would be
inconsistent with the public interest.
Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Recommended Decision
[FR Doc. 2011–22088 Filed 8–29–11; 8:45 am]
Conclusion
I recommend that Respondent’s
controlled substances registration be
revoked and his application for renewal
and modification of his DEA registration
be denied.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Dated: June 15, 2010.
Mary Ellen Bittner,
Administrative Law Judge.
Manufacturer of Controlled
Substances; Notice of Registration
[FR Doc. 2011–22093 Filed 8–29–11; 8:45 am]
By Notice dated April 15, 2011, and
published in the Federal Register on
April 27, 2011, 76 FR 23627, Cedarburg
Pharmaceuticals, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
4–Anilino-N-phenethyl-4–Piperidine
(8333), a basic class of controlled
substance listed in schedule II.
The company plans to use this
controlled substance in the
manufacturer of another controlled
substance.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Cedarburg Pharmaceuticals, Inc., to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Cedarburg Pharmaceuticals,
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35241, Wildlife
Laboratories, 1401 Duff Drive, Suite 400,
Fort Collins, Colorado 80524, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Wildlife Laboratories to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
VerDate Mar<15>2010
20:31 Aug 29, 2011
Jkt 223001
Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–22089 Filed 8–29–11; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
53961
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Harold Edward Smith, M.D.;
Revocation Of Registration
On April 17, 2009, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Harold Edward Smith,
M.D. (Respondent), of Mt. Dora, Florida.
The Show Cause Order proposed the
revocation of Respondent’s DEA
Certificate of Registration, BS4681979,
and the denial of any pending
applications to renew or modify the
registration, on the grounds that
Respondent had materially falsified
various applications for his DEA
registration and had committed acts
which render his registration
inconsistent with the public interest.
Show Cause Order at 1 (citing 21 U.S.C.
824(a)(1) & (4)).
The Show Cause Order alleged that
Respondent has ‘‘a documented
substance abuse history dating back as
far as 1982,’’ when he ‘‘entered
treatment for alcohol and controlled
substance abuse.’’ Id. The Order alleged
that on April 3, 1985, Respondent
entered into a consent order with the
Georgia Board of Medical Examiners
(Georgia Board) based on his ‘‘chemical
dependency,’’ which placed him on
probation for four years and imposed
various conditions including that he
‘‘abstain from the consumption of
alcohol or controlled substances,’’
undergo random drug testing, and
‘‘relinquish’’ his controlled substance
privileges. Id. The Order then alleged
that in June 1990, Respondent tested
positive for cocaine and that on October
10, 1990, he ‘‘entered into an Interim
Consent Order’’ with the Georgia Board
under which his medical license was
suspended and he was ordered (1) Not
to practice medicine, (2) not to use his
DEA registration, and (3) ‘‘to participate
in a program for impaired physicians.’’
Id. at 2.
Next, the Show Cause Order alleged
that during 1999 and 2000, Respondent
issued prescriptions for hydrocodone to
J.R.S. and L.L.S., and had failed to
maintain the ‘‘records of any
examinations, diagnoses, treatment[s] or
* * * drugs prescribed to these
individuals as required by Section
458.331(1)(q) of the Florida statutes.’’ Id.
The Order further alleged that based on
this conduct, Respondent ‘‘entered into
a Consent Agreement with the’’ Florida
Board of Medicine, which required him
to pay a fine of $5,000, desist ‘‘from
prescribing to family members’’ and to
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 76, Number 168 (Tuesday, August 30, 2011)]
[Notices]
[Page 53961]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22088]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 7, 2011, and published in the Federal Register
on June 16, 2011, 76 FR 35241, Wildlife Laboratories, 1401 Duff Drive,
Suite 400, Fort Collins, Colorado 80524, made application by renewal to
the Drug Enforcement Administration (DEA) to be registered as an
importer of Etorphine Hydrochloride (9059), a basic class of controlled
substance listed in schedule II.
The company plans to import the listed controlled substance for
sale to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Wildlife Laboratories to import the basic class of
controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Wildlife
Laboratories to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with State and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic class
of controlled substance listed.
Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-22088 Filed 8-29-11; 8:45 am]
BILLING CODE 4410-09-P
